Abstract

Specialized food products including biologically active additives (BAA) are becoming increasingly in demand in the consumer market taking into account their importance for improving people’s nutrition and health. The aim of the research is to develop probiotic confectionery of "Bifidopan" and "Laktopan" enriched with bifidobacteria (bifidobacterium adolescentis), lactobacilli (lactobacillus plantarum and lactobacillus acidophilus) and ascorbic acid in the following amount: bifidogum (1 * 1010 CFU, g / 100g) - 0.5; lactogum (1 * 1010 CFU, g / 100 g) and acidodum (1 * 1010 CFU, g / 100 g) - 0.25. The introduction reflects relevance of our research and the development of dietary supplements. To achieve this goal we used generally accepted and special research methods determined by technical regulations [9]. The article reflects the prescription composition, organoleptic indices, and nutritional value of the developed products. The results of the research on safety indices for candies are given as well as recommendations for doses of their consumption have been developed. We studied organoleptic, physical-chemical, sanitary-hygienic, sanitary and toxicology factors of quality and safety that allowed us to establish nutritional value of the developed products. The mass fraction of ascorbic acid mg / 100 g is 900; bifidobacteria (bifidobacterium adolescentis) (for sweets "Bifidopan") CFU / 100g is at least 5.0 * 109; lactic acid bacteria (lactobacillus plantarum and lactobacillus acidophilus) (for sweets "Laktopan") CFU / 100 g is at least 5.0 * 108; fats g / 100 g (averaged data) is 20.5; carbohydrates g / 100 g (averaged data) is 67.3. The energy value is 454 kcal. These indices as well as the analysis of probiotics participation in the regulation of metabolic processes determine the functional character of specialized confectionery products. Evidence of their effectiveness is provided by including them in the children diet as a comprehensive therapy for chronic gastroenteritis and gastrointestinal diseases. Normalization of intestinal microflora and clinical symptoms of the disease has been established against the background of improving self-awareness and general state of the body. High stability of BAA has been demonstrated by the example of the most labile component - ascorbic acid, which is explained by using gentle production process parameters that provide a slight level of humidity and aeration preventing undesired oxidation processes. Recommendations on the norms of consumption of the developed products are given. Based on the materials obtained, the conclusion on the possibility of using probiotic sweets as a source of functionally active bifido-, lactobacilli and ascorbic acid has been made. Specialized products have been tested under production conditions certified within the requirements of international standards ISO 9001, 22000 series and GMP rules, which ensures the stability of their quality characteristics and competitiveness.

Keywords

"Bifidopan" and "Lactopan" confectionery products, probiotic product, regulated quality indices, nutritional value, functional character

REFERENCES

1. Avstrievskih, A.N. Produkty zdorovogo pitaniya: novye tehnologii, obespechenie kachestva, effektivnost' primeneniya: monografiya / A.N. Avstrievskih, A.A. Vekovcev, V.M. Poznyakovskiy. - Novosibirsk: Sib. univ. izd-vo, 2005. - 416 s.
2. Vekovcev, A.A. Razrabotka, ocenka potrebitel'skih svoystv i effektivnosti pischevyh produktov i probioticheskogo naznacheniya: dis. … kand. tehn. nauk: 05.18.15: zaschischena 26.12.03 / Vekovcev Andrey Alekseevich. - Kemerovo, 2003. - 257 s.
3. Gur'yanov, Yu.G. Innovacionnye produkty zdorovogo pitaniya na osnove mestnogo syr'ya / Yu.G. Gur'yanov, V.M. Poznyakovskiy. - Kemerovo: Kuzbassvuzizdat, 2013. - 191 s.
4. Zdorov'e Rossii: atlas / Pod red. L.A. Bokeriya, 8-e izd. - M.:NCSSH im. A.N. Bakuleva RAMN, 2012. - 408 s.
5. Poznyakovskiy, V.M. Pischevye ingredienty i biologicheski aktivnye dobavki / V.M. Poznyakovskiy, O.V. Chugunova, M.Yu. Tamova. - M.: INFRA-M, 2017. - 143 s.
6. Rasporyazhenie Pravitel'stva Rossiyskoy Federacii ot 25.10.10 goda №559-r «Osnovy gosudarstvennoy politiki Rossiyskoy Federacii v oblasti zdorovogo pitaniya naseleniya na period do 2020 goda».
7. Rasporyazhenie Pravitel'stva Rossiyskoy Federacii ot 17.04.12 goda №559-r «Strategiya razvitiya pischevoy i pererabatyvayuschey promyshlennosti Rossiyskoy Federacii do 2020 goda».
8. Spirichev, V.B. Obogaschenie pischevyh produktov vitaminami i mineral'nymi veschestvami. Nauka i tehnologiya. / V.B. Spirichev, L.N. Shatnyuk, V.M. Poznyakovskiy; pod obsch. red. V.B. Spiricheva. - 2-e izd. - Novosibirsk: Sib. univ. izd-vo, 2005. - 548 s.
9. Tehnicheskiy reglament TS 027/2012 «O bezopasnosti otdel'nyh vidov specializirovannoy pischevoy produkcii, v tom chisle dieticheskogo, lechebnogo i dieticheskogo profilakticheskogo pitaniya».
10. Tutel'yan, V.A. Sovremennoe sostoyanie i perspektivy razvitiya nauki o pitanii / V.A. Tutel'yan, V.M. Poznyakovskiy // Sovremennye prioritety pitaniya, pischevoy promyshlennosti i torgovli: sb. nauch. trudov, posvyaschennyh yubileyu kafedry biotehnologii, tovarovedeniya i upravleniya kachestvom / pod obsch. red. V.M. Poznyakovskogo. - M.; Kemerovo: Izd. ob'ed. «Rossiyskie universitety»: «ASTSh: Kuzbassvuzizdat», 2006. - s. 5-10.
11. Ukaz Prezidenta Rossiyskoy Federacii V.V. Putina «O sovershenstvovanii gosudarstvennoy politiki v sfere zdravoohraneniya» (2011 g.)
12. History, present situation, and prospects of probiotic research conducted in the G.N. Gabrichevsky Institute for Epidemiology and Microbiology / V.A. Aleshkin, A.M. Amerhanova, V.V. Pospelova, S.S. Afanasiev, B.A. Shenderov // Microbial ecology in Yealth and Disease. - 2008. - R. 113-115.
13. Chen, C.C. Probiotics and prebiotics: role in clinical disease states / C.C. Chen, WA. Walker // Adv Pediatr. 2005. - R. 77-113.
14. Dietary odulation of the human colonic microbiota: Updating the concept of prebiotics / G.R. Gibson, H.M. Probert, J.A.E. Van Loo, M.B. Roberfroid // Nutr Res Rev. - 2004. - № 17. - R. 259-275.
15. Lourens, R.M. Human Breast Milk: Current Concepts of Immunology and Infectious Diseases / R. Lourens, A. Pane // Current Problems Pediatric and Adolescent Health Care. - 2007. - Vol. 37, №1. - P. 27-36.
16. Martin, C. Probiotics: Role in Pathophysiology and Prevention in Necrotizing Enterocolitis / C. Martin, W. Walker // Probiotics and NEC. - 2008. - № 32. - P. 127-137.
17. Principles and methods of microencapsulation of probiotic microorganisms / A. Mortazavian, S.N. Razavi, M.R. Ehsani, S. Sohrabvandi // Iranian J. of Biotechnology. - 2007. - Vol. 5, № 1. - P. 3-22.
18. Tannock, G. The search for disease-associated compositional shifts in bowel bacterial communities of humans / G. Tannock // Trends in Microbiology. - 2005. - Vol. 16, № 10. - P. 488-495.
19. Tannock, G. What immunologists should know about bacterial communities of the human bowel / G. Tannock // Seminars in Immunology. - 2007. - Vol. 19, № 2. - P. 94-105.